news
India's bioeconomy hit the $150 billion mark in 2023, two years ahead of projections. By 2024, it grew to $165.7 billion. This growth aligns with strategies in the National Biotech Development Strategy 2021, focusing on innovation, manufacturing, and strategic initiatives by the Department of Biotechnology and BIRAC.
news
Dr Jitendra Singh inaugurated a state-of-the-art Central Facility for Recombinant Cells and Sensors at BRIC-RGCB, Thiruvananthapuram, Kerala. The Rs 60 crore facility aims to enhance drug discovery, medical, and Agri genomics. The event highlighted India's shift towards a bio-driven economy with biotechnology as a pivotal sector for future
news
On the 40th Foundation Day of the Department of Biotechnology (DBT), Union Minister Dr. Jitendra Singh introduced the SUJVIKA AI-driven Biotech Product Data Portal. Created with industry partner ABLE, it offers structured biotechnology import data to support domestic biomanufacturing and research. Celebrations highlighted India's target of a $1
news
Union Minister Dr Jitendra Singh launched the first national call for the ₹2,000 crore BIRAC–RDI Fund under India's ₹1 lakh crore Research, Development, and Innovation (RDI) initiative to advance biotechnology. This strategic move aims to enhance India's position in global bioeconomy leadership by bridging
news
Dr. Jitendra Singh inaugurated a SAMARTH Skill Centre and a technology incubator at the Centre for DNA Fingerprinting and Diagnostics in Hyderabad, marking India's shift towards genomics and biotechnology in healthcare. The Minister highlighted the government's focus on early detection, personalised medicine, and affordable treatment, especially
news
Union Minister Dr. Jitendra Singh inaugurated the new BRIC Secretariat in New Delhi, marking a significant step towards enhancing India's bioeconomy. The office will coordinate across 14 institutes under the Biotechnology Research and Innovation Council for better collaboration and integration, under the Department of Biotechnology's BioE3
news
In 2025, India has observed significant advancements in its biotechnology sector, propelled by government-supported initiatives and policies. The country's bio-economy has scaled markedly, from $10 billion in 2014 to $165.7 billion in 2024, with projections to reach $300 billion by 2030. The Department of Biotechnology has been
Biotechnology
During the Second Foundation Day of the Biotechnology Research & Innovation Council (BRIC), Dr. Jitendra Singh emphasized India's leadership in the biotechnology sector, highlighting the country's exclusive Biotechnology policy, BiOE3. He announced the launch of the BRIC–BIRAC Entrepreneur-in-Residence Program and noted the significant growth of
Bioinnovation
Union Minister Dr. Jitendra Singh emphasized the importance of leveraging regional strengths to build a robust bioinnovation ecosystem in India during a review meeting of the Department of Biotechnology (DBT). He highlighted ongoing projects aimed at expanding the country's bio-innovation landscape, including the mapping of states based on
Nafithromycin
India has successfully developed its first indigenous antibiotic, Nafithromycin, effective against resistant respiratory infections, particularly benefiting cancer patients and diabetics. This achievement, a collaboration between the Department of Biotechnology and Wockhardt, highlights the importance of a self-sustainable innovation ecosystem. Additionally, a breakthrough in gene therapy for Hemophilia has been reported,
Gene Therapy
Dr. Jitendra Singh inaugurated the 10th Annual 'Cell and Gene Therapy' Symposium at CMC Vellore, highlighting CSCR's achievement in India's first human gene therapy trial for Hemophilia A. He emphasized the importance of affordable gene therapy and advancements in India's biomanufacturing sector,
Pharma Exports
India's pharmaceutical exports, currently valued at approximately $27.8 billion, are projected to exceed $30 billion by the end of this year, according to Dr. Jitendra Singh, Union Minister of State for Science and Technology. The domestic pharma market, valued at $60 billion, is expected to double to